Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors

Cancer Research

Volumn 61, Issue 18, 2001, Pages 6762-6767

  Gicquel, Christine ^a   Bertagna, Xavier ^b   Gaston, Víronique ^a   Coste, Joël ^b   Louvel, Albert ^b   Baudin, Eric ^e   Bertherat, Jérome ^b   Chapuis, Yves ^b   Duclos, Jean Marc ^d   Schlumberger, Martin ^e   Plouin, Pierre Franêois ^c   Luton, Jean Pierre ^b   Le Bouc, Yves ^a  

^a ARMAND TROUSSEAU HOSPITAL   (France)

^b Hôpital Cochin ^*  (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d SAINT JOSEPH HOSPITAL   (France)

^e INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ADRENAL CORTEX TUMOR; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RECURRENCE; COHORT ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENE EXPRESSION REGULATION; GENETIC HETEROGENEITY; HETEROZYGOSITY LOSS; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RELIABILITY; TUMOR LOCALIZATION;

ADOLESCENT; ADRENAL CORTEX NEOPLASMS; ADULT; AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 17; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION; HUMANS; INSULIN-LIKE GROWTH FACTOR II; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES;

EID: 0035884186     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Extensive personal experience. Adrenocortical tumors
2. Adrenocortical carcinoma: Pathogenesis and treatment
3. Clonal composition of human adrenocortical neoplasms
4. Clonal analysis of human adrenocortical carcinomas and secreting-adenomas
5. Genetic aberrations in adrenocortical tumors detected using comparative genomic hybridization correlate with tumor size and malignancy
6. Genotyping of adrenocortical tumors: Very frequent deletions of the MEN1 locus in 11q13 and of a 1-centimorgan region in 2p16
7. Insulin-like growth factors (IGFs) and their receptors in adrenal tumors: High IGF-II expression in functional adrenocortical carcinomas
8. Rearrangements at 11p15 locus and overexpression of insulin-like growth factor-II gene in sporadic adrenocortical tumors
9. Structural and functional abnormalities at 11p15 are associated with the malignant phenotype in sporadic adrenocortical tumors. Study on a series of 82 tumors
10. Genetic changes in human adrenocortical carcinomas
11. Recent advances in the pathogenesis of adrenocortical tumours
12. MEN1 gene analysis in sporadic adrenocortical tumors
13. MEN1 gene mutation analysis of sporadic adrenocortical lesions
14. Complete sequencing and messenger ribonucleic acid expression analysis of the MEN I gene in adrenal cancer
15. Clinical features of adrenocortical carcinoma, prognostic factors and the effect of mitotane therapy
16. Cancer of the adrenal cortex: The natural history, prognosis and treatment in a study of fifty-five cases
17. Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors
18. Pathologic features of prognostic significance in adrenocortical carcinomas
19. Variable number of tandem repeat (VNTR) markers for human gene mapping
20. A BamHI polymorphism is detected by a genomic p53-clone (pBHP53)
21. Codon 72 polymorphism of the TP53 gene
22. Evidence for a second tumor suppressor gene on chromosome 17p linked to high S-phase index in primary human breast carcinomas
23. Prognostic significance of loss of heterozygosity at loci on chromosome 17p13.3-ter in sporadic breast cancer is evidence for a putative tumour suppressor gene
24. P53 mutations in sporadic adrenocortical tumors
25. Mutations of the p53 gene in human functional adrenal neoplasms
26. P53 mutations in human adrenocortical neoplasms: Immunohistochemical and molecular studies
27. P53 mutations in adrenal tumors: Caucasian patients do not show exon 4 "hot spot" found in Taiwan
28. Spatial organization of ABR and CRK genes on human chromosome band 17p13.3
29. P53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3
30. Identification of two candidate tumor suppressor genes on chromosome 17p13.3
31. Physical and transcriptional mapping of the 17p13.3 region that is frequently deleted in human cancer
32. The role of the insulin-like growth factor system in human cancer
33. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth
34. Autocrine role of IGF-II in proliferation of human adrenocortical carcinoma NCI H295R cell line
35. KIP2, a cyclin dependent kinase inhibitor with unique domain structure and tissue distribution
36. CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene
37. Tumour-suppressor activity of H19 RNA
38. Genomic imprinting of a human apoptosis gene homologue, TSSC3
39. Somatic mutation of TSSC5, a novel imprinted gene from human chromosome 11p15.5
40. Ribonucleic acid expression of the clustered imprinted genes, p57KIP2, insulin-like growth factor II, and H19, in adrenal tumors and cultured adrenal cells
41. High expression of cyclin E and G1 CDK and loss of function of p57KIP2 are involved in proliferation of malignant sporadic adrenocortical tumors